{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Baudette",
      "state": "MN",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "89556",
      "recalling_firm": "ANI Pharmaceuticals, Inc.",
      "address_1": "210 W Main St",
      "address_2": "N/A",
      "postal_code": "56623-2467",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide within the United States",
      "recall_number": "D-0568-2022",
      "product_description": "Pyrazinamide Tablets, USP 500 mg, 100-count bottles, Rx only, Manufactured by: ULTRAtab Laboratories, Inc. Highland, NY 12528, Distributed by Par Pharmaceuticals, Chestnut Ridge, NY 10977, NDC 67253-660-10.",
      "product_quantity": "5,477 bottles",
      "reason_for_recall": "cGMP Deviations",
      "recall_initiation_date": "20220215",
      "center_classification_date": "20220217",
      "termination_date": "20221025",
      "report_date": "20220223",
      "code_info": "Lot #: 19B064A, Exp. Date 03/2022"
    }
  ]
}